The two COVID-19 vaccines that recently received emergency approval from the U.S. and other worldwide regulatory agencies are expected…
Articles by Forest Ray PhD
The National Fragile X Foundation (NFXF) will host a virtual patient-focused drug development (PFDD) meeting for fragile X syndrome…
The National Fragile X Foundation (NFXF) has launched the International Fragile X Premutation Registry to assist and encourage research…
A Phase 1 clinical trial is recruiting adults with fragile X syndrome to study the brain processes underlying altered…
The U.S. Department of Education awarded $2.1 million to the University of California, Davis, MIND Institute to create a…
Connecta Therapeutics raised €1.7 million (about $2 million) in investments that will enable it to bring a potential…
Almost half of emergency department visits for fragile X syndrome result in hospitalizations, according to a nationwide study in…
Same But Different, a U.K. nonprofit that uses the arts to bring communities together, is holding a calendar photography…
Raremark, an online rare disease patient community, has launched a digital platform called Xperiome, aimed at streamlining the…
Better communication among different institutions is needed to assist young patients with fragile X syndrome make the transition from…